Shenzhen Chipscreen Biosciences Co (SHSE:688321) Beneish M-Score: -1.65 (As of Jul. 01, 2026)


SHSE:688321 Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
73 GF Score
Price ¥28.46
GF Value ¥37.66
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shenzhen Chipscreen Biosciences Co Beneish M-Score?

Shenzhen Chipscreen Biosciences Co SHSE:688321 +8.09% 73 Beneish M-Score is -1.65 as of Jul. 01, 2026. GuruFocus rates SHSE:688321 with a GF Score™ of 73/100 and a GF Value™ of ¥37.66 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 909 Drug Manufacturers companies, Shenzhen Chipscreen Biosciences Co ranks worse than 86.8% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.65 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Shenzhen Chipscreen Biosciences Co's Beneish M-Score or its related term are showing as below:

SHSE:688321' s Beneish M-Score Range Over the Past 10 Years
Min: -3.18   Med: -2.32   Max: -1.17
Current: -1.65

During the past 10 years, the highest Beneish M-Score of Shenzhen Chipscreen Biosciences Co was -1.17. The lowest was -3.18. And the median was -2.32.


Shenzhen Chipscreen Biosciences Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shenzhen Chipscreen Biosciences Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Chipscreen Biosciences Co Beneish M-Score Chart

Shenzhen Chipscreen Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.96 -2.78 -1.63 -2.90 -1.98

Shenzhen Chipscreen Biosciences Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.81 -2.58 -2.11 -1.98 -1.65

SHSE:688321 vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Chipscreen Biosciences Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's Beneish M-Score falls into.


SHSE:688321
73GF Score
Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Chipscreen Biosciences Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shenzhen Chipscreen Biosciences Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.4615+0.528 * 0.9894+0.404 * 0.8407+0.892 * 1.4571+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8995+4.679 * -0.000643-0.327 * 0.825
=-1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥317 Mil.
Revenue was 257.039 + 235.904 + 267.559 + 244.335 = ¥1,005 Mil.
Gross Profit was 220.535 + 204.36 + 235.63 + 213.869 = ¥874 Mil.
Total Current Assets was ¥2,064 Mil.
Total Assets was ¥4,582 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,336 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥290 Mil.
Total Current Liabilities was ¥805 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,053 Mil.
Net Income was 28.272 + -19.808 + 41.175 + 48.747 = ¥98 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 24.344 + 37.043 + -2.136 + 42.079 = ¥101 Mil.
Total Receivables was ¥149 Mil.
Revenue was 162.264 + 176.834 + 178.955 + 171.556 = ¥690 Mil.
Gross Profit was 138.971 + 149.14 + 155.696 + 149.896 = ¥594 Mil.
Total Current Assets was ¥1,135 Mil.
Total Assets was ¥3,312 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,161 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥221 Mil.
Total Current Liabilities was ¥481 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,146 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(317.142 / 1004.837) / (148.919 / 689.609)
=0.315615 / 0.215947
=1.4615

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(593.703 / 689.609) / (874.394 / 1004.837)
=0.860927 / 0.870185
=0.9894

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2064.481 + 1335.956) / 4581.933) / (1 - (1134.828 + 1161.136) / 3311.703)
=0.25786 / 0.306712
=0.8407

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1004.837 / 689.609
=1.4571

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1161.136)) / (0 / (0 + 1335.956))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(290.157 / 1004.837) / (221.377 / 689.609)
=0.28876 / 0.321018
=0.8995

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1052.547 + 805.158) / 4581.933) / ((1146.022 + 481.443) / 3311.703)
=0.405441 / 0.491428
=0.825

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(98.386 - 0 - 101.33) / 4581.933
=-0.000643

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shenzhen Chipscreen Biosciences Co has a M-score of -1.65 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.65 mean?
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Beneish M-Score of -1.65 as of Jul. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. According to the industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #789 out of 909 companies in the Drug Manufacturers industry, placing it in the top 86.8%.
Is Shenzhen Chipscreen Biosciences Co's Beneish M-Score too high?
Shenzhen Chipscreen Biosciences Co's current Beneish M-Score is -1.65. Based on the distribution chart, Shenzhen Chipscreen Biosciences Co ranks #789 out of 909 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #789 out of 909 companies for Beneish M-Score. This places Shenzhen Chipscreen Biosciences Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. Shenzhen Chipscreen Biosciences Co's current Beneish M-Score is -1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥37.66, compared to a current price of ¥28.46 — trading 24.4% below its estimated fair value. The current Beneish M-Score is -1.65. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Beneish M-Score is -1.65 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued. The current stock price of ¥28.46 is trading 24.4% below its estimated GF Value™ of ¥37.66. GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Modestly Undervalued.

Key valuation signals for SHSE:688321:

  • Beneish M-Score: -1.65
  • GF Value™: ¥37.66 vs. price of ¥28.46 (24.4% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shenzhen Chipscreen Biosciences Co Business Description

Address No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.
73GF Score

Get the complete analysis for SHSE:688321

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.46
Price
¥37.66
GF Value